Ajanta Pharma (BOM:532331) EPS (Basic) : ₹69.59 (TTM As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma EPS (Basic)?

Ajanta Pharma's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was ₹17.27. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹69.59.

Ajanta Pharma's EPS (Diluted) for the three months ended in Sep. 2024 was ₹17.26. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹69.55.

Ajanta Pharma's EPS without NRI for the three months ended in Sep. 2024 was ₹17.26. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was 69.55.

During the past 12 months, Ajanta Pharma's average EPS without NRIGrowth Rate was 33.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 8.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Ajanta Pharma's highest 3-Year average EPS without NRI Growth Rate was 66.30% per year. The lowest was -2.70% per year. And the median was 30.10% per year.

Ajanta Pharma EPS (Basic) Historical Data

The historical data trend for Ajanta Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma EPS (Basic) Chart

Ajanta Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

35.73

50.06

54.97

45.89

64.82

Ajanta Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															15.51	16.68	16.10	19.54	17.27

Ajanta Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Ajanta Pharma's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(8161.7	-	0)	/	125.916
	=	64.82

Ajanta Pharma's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(2164.8	-	0)	/	125.350
	=	17.27

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹69.59

Ajanta Pharma (BOM:532331) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Ajanta Pharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Ajanta Pharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Ajanta Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (BOM:532331) » Definitions » EPS (Basic)

Traded in Other Exchanges

AJANTPHARM:India

Address

Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067

Website

https://www.ajantapharma.com

Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a presence while generating the vast majority of its revenue in India. The company aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, creams, injectables, capsules, liquids, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma Headlines

No Headlines